Literature DB >> 8381087

Suppression of normal human hematopoiesis by cytomegalovirus in vitro.

F R MacKintosh1, J Adlish, S W Hall, S St Jeor, E Smith, M Tavassoli, E D Zanjani.   

Abstract

Human cytomegalovirus (HCMV) infection is associated with marrow suppression in immunocompromised patients. To examine the mechanism(s) underlying this suppression, the effect of a laboratory strain of HCMV (AD169) and a clinical isolate of HCMV on colony formation by normal human marrow (BMC) hematopoietic progenitors in the presence and/or absence of monocyte/macrophages (MO) and T cells was studied. Direct addition of HCMV at multiplicity of infection (MI) of 0.1 to 5 to BMC produced dose-dependent inhibition of colony forming unit-mix (CFU-Mix) (30-82%), CFU granulocyte, macrophage (CFU-GM) (15-98%), and burst forming unit-erythroid (BFU-E) (23-86%); no consistent effect of CFU-erythroid (CFU-E) was noted. This inhibition occurred both with the direct addition of HCMV to the culture plates as well as by the preincubation of BMC with HCMV followed by washing of the cells; significant inhibition (p < 0.01) of colony formation occurred after 1 hour of incubation at MI of 5. No suppression of colony formation occurred when UV-irradiated virus was used. The inhibitory effect of HCMV was reduced when MO and T cells were removed prior to exposure of marrow to virus at MI of 1 to 5. At MI of 20, however, HCMV suppressed colony formation by BMC depleted of MO and T cells by about 40%. Coculture of autologous or allogeneic T cells, but not MO, exposed to HCMV with intact or depleted marrow resulted in inhibition of CFU-Mix (51%), CFU-GM (40%), and BFU-E (37%). The inhibitory effect of virus-exposed T cells did not appear to be mediated through a soluble factor. T cells expressing CD8 antigen were most active in this process; natural killer (NK) cells were not active. These results suggest that the suppressive effect of HCMV on hematopoiesis may be mediated in part through T lymphocytes.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8381087

Source DB:  PubMed          Journal:  Exp Hematol        ISSN: 0301-472X            Impact factor:   3.084


  5 in total

1.  Stem cell through present and future.

Authors:  Vijay K Sharma; Utpal K Singh; Rajniti Prasad; Sophie Fletcher
Journal:  Indian J Pediatr       Date:  2009-04-18       Impact factor: 1.967

2.  Monitoring of cytomegalovirus infection and disease in bone marrow recipients by reverse transcription-PCR and comparison with PCR and blood and urine cultures.

Authors:  J Gozlan; J P Laporte; S Lesage; M Labopin; A Najman; N C Gorin; J C Petit
Journal:  J Clin Microbiol       Date:  1996-09       Impact factor: 5.948

Review 3.  Growth factors and hematopoietic recovery.

Authors:  S C Gulati; R Gopal; J B Prowda; S Spanik; M Jain; A Gopal
Journal:  Med Oncol       Date:  1994       Impact factor: 3.064

4.  The effect of human cytomegalovirus on the formation of CFU-MK in vitro.

Authors:  Junxia Yao; Sanjun Song; Lihua Hu
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2004

5.  KSHV/HHV-8 infection of human hematopoietic progenitor (CD34+) cells: persistence of infection during hematopoiesis in vitro and in vivo.

Authors:  William Wu; Jeffrey Vieira; Nancy Fiore; Prabal Banerjee; Michelle Sieburg; Rosemary Rochford; William Harrington; Gerold Feuer
Journal:  Blood       Date:  2006-03-16       Impact factor: 22.113

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.